VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuber...
NEW YORK, Oct. 30 /PRNewswire/ --
See video from Novartis at:
Novartis announced that the US Food and Drug Administration (FDA) has approved Afinitor®; (everolimus) tablets for patients with subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS), who require therapeutic intervention but are not candidates for curative surgical resection. Available material includes soundbites.
thenewsmarket.com delivers free broadcast- and streaming-quality video and multimedia content directly to media around the world, 24/7. More than 25,000 media outlets in 190+ countries use thenewsmarket.com, including the AP, BBC, CNBC, CNN, France 24, N24, nytimes.com, RAI, TVE and ZDF.
Registered journalists can access video, audio, text, graphics and photos at http://www.thenewsmarket.com.
If you are not already registered, please take a moment to sign up - registration is quick and free: http://www.thenewsmarket.com/registration